IBC Life Sciences, division of Informa, today announced that the 11th annual BioProcess International (BPI) conference & exhibition will be held from October 20-23 at the Hynes Convention Center in Boston, MA. BPI is the largest annual event where all segments involved in the development and manufacture of biologics gather to network, collaborate and learn about the most advanced bio-processing methods. This year’s BPI event promises to be the largest and most dynamic edition yet with more than 1500 delegates from around the world, five keynotes presentations, 160 speakers, 80+ posters and 150+ exhibitors.“At GE Healthcare we are looking for an understanding of bioprocessing from start to finish, from cells to formulated drug substance. Going to BPI we see all of these aspects represented in the program and meet all those people working across that value chain,” said Guenter Jagschies, Ph.D. Senior Director, Strategic Customer Relations, GE Healthcare Life Sciences, Sweden. “BPI is an ideal event where our ideas meet those of our customers and peers.”
The conference program covers the full BioProcess spectrum including upstream processing, downstream processing, formulation and delivery, manufacturing strategy, analytical and quality and a new early stage company session on moving quickly from IND to the clinic.In addition, BPI features four one-day pre-conference symposiums and four two-day intensive training courses on ADCs, cell therapy bioprocessing, knowledge management, process development, quality risk management, CMC analytical, comparability and stability studies, technology transfer and introduction to biopharmaceutical manufacturing. Download the agenda to see the full program.
This year’s BPI exhibit hall will feature the BPI Theater, designed to showcase the industry’s latest products and innovations. The theater will host live product demonstrations, panel discussions, rebroadcast keynote presentations and host live interviews with leading thought-leaders.
Featured in the BPI Theater will be companies who are in the forefront enabling the development of new biological products with new product launches, including Pall Life Sciences, Meissner Filtration and Sartorius Stedim Biotech.
Another powerful feature of this year’s event is the addition of partnering360®, the largest online network of life science dealmakers. Delegates will be granted exclusive access to a BPI specific partnering360® networking tool that will enable them to identify and schedule meetings with potential partners, and foster deeper engagement before, during and following the event.Significant partnering opportunities exist for biopharmaceutical firms developing new and improved biologics including mAbs, vaccines, ADCs, recombinant proteins, bispecifics, enzymes, biosimilars and cell/gene therapy.
About IBC Life Sciences
IBC Life Sciences, a division of Informa, is your connection to the life sciences industry. Through conferences, webinars, podcasts and its suite of integrated marketing solutions, IBC Life Sciences delivers expert knowledge, valuable connections and customized offerings so customers can meet their goals. www.IBCLifeSciences.com
IBC Life Sciences hosts the annual BioProcess International™ (BPI) Conference and Exhibition. The BioProcess International Conference & Exhibition is where the biologics value chain meets to do business. Each year BPI attracts over 1500 biologics industry leaders for four days of power networking and learning. No other industry event delivers the high-level connections and insight needed to accelerate your business. Use this preeminent industry platform to showcase your company, products and thought leadership. To get involved, visit www.IBCLifeSciences.com/BPI
Contact: Dawn O’Connor; Senior Marketing Manager; IBC Life Sciences
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment